Family-based methods are a potentially powerful tool to identify trait-defining genetic variants in extended families, particularly when used to complement conventional association analysis. We utilized two-point linkage analysis and single variant association analysis to evaluate whole exome sequencing (WES) data from 1205 Hispanic Americans (78 families) from the Insulin Resistance Atherosclerosis Family Study. WES identified 211,612 variants above the minor allele frequency threshold of ࣙ0.005. These variants were tested for linkage and/or association with 50 cardiometabolic traits after quality control checks. Two-point linkage analysis yielded 10,580,600 logarithm of the odds (LOD) scores with 1148 LOD scores ࣙ3, 183 LOD scores ࣙ4, and 29 LOD scores ࣙ5. The maximal novel LOD score was 5.50 for rs2289043:T>C, in UNC5C with subcutaneous adipose tissue volume. Association analysis identified 13 variants attaining genome-wide significance (P < 5 × 10 −08 ), with the strongest association between rs651821:C>T in APOA5
Introduction
Despite its success in the study of Mendelian disorders, familybased linkage analysis has shown a limited ability to identify genetic variants underlying complex traits or disease. Genome-wide association studies (GWAS) have largely become the discovery method of choice in the search for variants associated with complex traits or diseases (Ott et al., 2015) . However, GWAS approaches have limitations. Notably, the majority of GWAS have been performed in European-derived populations, and thus far, the loci identified by these studies have, in many cases, provided limited information about traitor disease-associated variants in other ethnicities (Rosenberg et al., 2010; Bowden, 2011) . In addition, GWAS require very large sample sizes to achieve sufficient power and, with few exceptions, primarily identify common genetic variants that account for a small proportion of the heritability of most complex diseases (Manolio et al., 2009) . A major advantage of family-based linkage analysis is its inherent potential to identify high-impact variants, especially low-frequency (i.e., minor allele frequency [MAF] > 0.005) variants in moderately sized familial cohorts (Bowden, 2011) . Additionally, familybased linkage can be a powerful tool even in moderately sized families for detecting loci near causal variants. The benefits of gene discovery efforts in families are well known, particularly the ability to limit the number of causative genes and/or pathways involved in disease (Borecki & Province, 2008) .
Whole exome sequencing (WES) has recently become a practical approach for identifying coding variants regardless of their frequency within a population Albrechtsen et al., 2013) . When combined with family-based linkage analysis and complemented with association analysis, it can be a powerful, cost-effective method for elucidating variants of biomedical relevance (Gazal et al., 2016) . Drawing on the strengths of both methods, two-point linkage analysis and conventional association analysis have been implemented in parallel to search for coding variants that substantially contribute to the variance within traits. The ability of this integrated approach to precisely align single nucleotide polymorphism (SNP) results for the two analyses is a significant advantage, highlighting variants that may show evidence of both nominal significance and moderate linkage at a given locus, and uncovering variants that may not have been identified by either analysis alone.
Previously these approaches have been applied to exome chip data from 130 African American and Hispanic American families comprising the Insulin Resistance Atherosclerosis Family Study (IRASFS) (Hellwege et al., 2014) with a panel of cardiometabolic phenotypes. Here, we have explored the value of WES in 78 Hispanic American families from IRASFS. We hypothesized that the WES dataset would significantly expand the number of coding variations for analysis and identify novel coding variants associated and/or linked to cardiometabolic disease.
Materials and Methods

Samples
The IRASFS is a family-based study designed to identify genetic and environmental determinants of insulin resistance and visceral adiposity in Hispanic American and African American populations (Henkin et al., 2003) . This report involved DNA samples (n = 1221) from 78 families in the Hispanic American cohort from two locations: San Antonio, TX and San Luis Valley, CO. An extensive number of measurements relevant to cardiometabolic disease had previously been collected for these subjects, including those pertaining to glucose homeostasis, blood lipids, anthropometric traits, and fat deposition. All clinical and analysis sites secured institutional review board approval, and informed consent was obtained from all participants.
Exome Sequencing
Exome sequencing was performed using the Illumina Nextera Expanded Exome Enrichment kit (Illumina, Inc.; San Diego, CA) in conjunction with an Illumina HiSeq 2500 sequencer. This platform covered 62 Mb of exonic sequence and, in comparison to other panels, increased the coverage of untranslated regions (UTRs) and microRNAs (miRNAs), targeting 20,794 genes. Exome-enriched samples were amplified, and the resulting library was loaded onto an Illumina flow cell for cluster generation (standard clonal amplification) using the Illumina TruSeq paired-end cluster kit v2. The flow cell was then transferred to the HiSeq 2500 instrument for parallel sequencing by synthesis using the Illumina TruSeq SBS kit for the HiSeq for 200 cycles. Forty-eight samples per flow cell were sequenced using paired-end reads and multiplexing six samples per lane. Additionally, a PhiX control (Illumina, Inc.; San Diego, CA) was spiked into a flow cell lane.
Data Processing
All sequence reads were passed through the Illumina Data Analysis Pipeline. Raw intensity files were converted to sequences with preliminary quality scores using intensity and phasing correction, base determination and preliminary quality score estimation. Sequencing image analysis and base calling of sequences into FASTQ files were performed using the instrument's Sequencing Control Software Real Time Analysis (SCS/RTA) software. Participant samples were demultiplexed using CASAVA v1.8 (Illumina, Inc.; San Diego, CA). Quality control (QC) metrics of the unmapped sequence reads were collected using FastQC (http://www.bioinformatics.babraham. ac.uk/projects/fastqc/). All sequence reads from samples passing QC criteria were mapped to the human genome reference sequence (hg19) using the Burrows-Wheeler Alignment tool (BWA) ) software, which was implemented in parallel on an 8000 processor computing cluster. BWA-generated alignments in Sequence Alignment/Map (SAM) format were converted to Binary SAM (BAM) format, sorted, and indexed using SAMtools . Alignments from samples of the same subject were merged into a single BAM file to which the base call quality recalibration and indel realignment methods from the Genome Analysis Toolkit (GATK) (McKenna et al., 2010; DePristo et al., 2011) were applied. Coverage and other postalignment QC metrics were collected using BEDTools (Quinlan and Hall, 2010) , SAMtools, and GATK. SNP and indel variant discovery were carried out across several related and unrelated subjects simultaneously. Both mpileup from SAMtools and the UnifiedGenotyper method from GATK were used, together creating a combination of parameter-based hard-filtering and variant quality score recalibration (DePristo et al., 2011) . Known annotations anchored to the proper human genome reference used for the alignments were added to the detected variant sites using ANNOVAR and/or variant tools (San Lucas et al., 2012) . Annotated variants and genotype calls were stored in bgzip (SAMtools)-compressed VCF files.
Low-quality samples (n = 3) with mean depth <20 were removed prior to analysis, as well as SNPs with fewer than 3000 reads. Restricting to variants with mean sample depth >5 resulted in 555,651 SNPs of high quality. The final mean depth of the sequencing was 60.3X (range = 4.2 -106.4X). Supplementary Table 1 provides the transition/transversion (Ti/Tv) ratios broken down by SNP category for all variants included in the final analysis. The mean concordance with SNPs genotyped on the exome array (n = 49,714) (Hellwege et al., 2014) was 99.93%. During QC, one sample was removed for low concordance with SNPs on the exome array, one sample was removed for a substantial number of Mendelian inconsistencies, and an additional five samples were removed for inconsistencies between X and Y marker calls and participant gender. SHAPEIT2 (O'Connell et al., 2014) was used to perform Mendelian error checking with regard to established pedigree structures. Discordant genotypes were imputed to genotypes consistent with the pedigree structure, and individual SNPs with <95% efficiency were zeroed out. Samples found to have <95% overall efficiency by SHAPEIT2 (n = 6) were excluded from the analysis.
Statistical Analysis
SNP data were analyzed for both two-point family-based linkage and single variant association using Sequential Oligogenic Linkage Analysis Routines (SOLAR) (Almasy & Blangero, 1998) . Briefly, both analyses were performed using the variance components method implemented in SOLAR, with age, sex, recruitment center (in the Hispanic cohorts), ancestry proportions (one to three principal components depending on ethnic group), and body mass index (BMI) as covariates. The measured genotype analysis, which accounts for the nonindependence of family members, involves incorporating each variant separately in a model as a measured covariate (the number of copies of the minor allele) evaluating genotypespecific differences in the trait means. These approaches have been documented in detail previously (Hellwege et al., 2014 (Hellwege et al., , 2016 . Waist-to-hip ratio (WHR), waist circumference, visceral adipose tissue area (VAT), and visceral to subcutaneous tissue ratio (VSR) were evaluated both with and without adjustment for BMI. Other measures of adiposity, including body adiposity index (BAI), subcutaneous adipose tissue area (SAT), and percent body fat, did not include BMI as a covariate. Table S2 shows the phenotypes analyzed in this study and, where relevant, the transformations used to approximate normality. The presence of a low-frequency variant encoding the G45R missense mutation in ADIPOQ (rs200573126:G>C) was included as a covariate for analyses involving adiponectin (ADP_G45R), as this variant is known to have a strong influence on adiponectin levels in this population (Bowden et al., 2010; Hellwege et al., 2015) . Additionally, three admixture proportions were included as covariates in the association analysis. Estimates of admixture proportion had previously been computed by maximum likelihood estimation (MLE) of individual ancestries in ADMIXTURE after pruning for linkage disequilibrium (LD) and assuming five ancestral populations (K = 5) to produce admixture estimates for the largest number of samples (Hellwege et al., 2014) . Three of the five variables considered were selected as representative of the variation in these Hispanic samples, as they encompassed the majority of the variability.
Results
Demographic information, along with biometric and lipid characteristics of the samples relevant to this analysis, is shown in Table S3 . Overall, 555,651 variants were identified from WES with average depth of 60.3X in up to 1205 Hispanic individuals from 78 families. To exclude variants found only in 12 individuals or less, a minor allele frequency (MAF) threshold was set at 0.5%, resulting in a set of 211,612 SNPs for analysis. Of the variants meeting the MAF threshold, 11,973 (5.66%) were previously unknown (relative to the National Center for Biotechnology Information's Database of Single Nucleotide Polymorphisms (dbSNP) build 138).
Linkage
Linkage analysis for each variant with 50 metabolic traits yielded 10,580,600 logarithm of the odds (LOD) scores with 1148 LOD scores ࣙ3, 183 LOD scores ࣙ4, and 29 LOD scores ࣙ5. The highest LOD score was in a previously identified broad linkage peak on chromosome 3 for adiponectin levels (Bowden et al., 2010) . Excluding variants linked with adiponectin (not adjusted for the G45R variant), there were 1060 LOD scores ࣙ3, 68 LOD scores >4, and 20 LOD scores >4.5 (Table 1) . Of these variants, the most biologically relevant result was evidence of linkage with SAT on chromosome 4 (rs2289043:T>C; LOD = 5.49; Figure 1 ). This missense mutation (Met721Thr) is within UNC5C, which encodes a member of the UNC5H netrin receptor family. Additional strong linkage signals included rs35705:G>A (intronic) in GAS2L3 with gamma-glutamyl transpeptidase levels (LOD = 5.33), rs116505219:A>C (missense; Phe51Cys) in AQP12B with adiponectin levels (LOD = 5.30), and rs974334:G>C (intronic; GPX6) and rs139032867 (NP_653272.2:p.Gly133_Gly135del; FAM109A) with WHR adjusted for BMI (WHR_BMI; LOD = 5.13 and 5.02, respectively).
In addition to specific variants, there were several notable broad linkage peaks. Most strikingly, a 67.5-Mb region of chromosome 10, including the majority of the p arm and a large portion of the proximal q arm, showed evidence of linkage (LOD >3.0) with systolic blood pressure (SBP). The highest LOD score in this peak was 4.41 at rs74832669:G>T, a variant within the 3´-UTR of SLC18A3 (Solute Carrier Family 18, Member 3). This gene encodes a transmembrane protein that transfers acetylcholine into vesicles for secretion into extracellular space. Three additional variants within SLC18A3 (rs2269338:G>T, rs8175353:C>T, and rs1880675:C>T) had LOD scores above 4.0.
Additional broad linkage peaks included a region on chromosome 1 with acute insulin response (33 variants with LOD >3 in the peak and 3 with LOD >4; Table S4 ) and a region on chromosome 12 with adiponectin levels (adjusted for G45R), both consistent with our previous findings (Hellwege et al., 2016) . A smaller region on chromosome 6 was observed to show evidence of linkage with WHR_BMI. A number of variants within this linkage peak were located within human leukocyte antigen genes, including HLA-C, HLA-DQA2, and HLA-DQB2. The GPX6 variant described above was also located within this region.
Association
Thirteen variants attained conventional genome-wide significance (P < 5.0 × 10 −8 ; Table 2 ), with the strongest association between rs651821:C>T, a 5´-UTR variant in APOA5, and triglyceride levels (P = 3.67 × 10 −10 ). Apolipoprotein AV is known to be involved in the regulation of plasma triglyceride levels (Pennacchio et al., 2002 (Pennacchio et al., , 2001 ). Other genes containing variants significantly associated with cardiometabolic phenotypes included the well-documented PNPLA3 gene association with measures of hepatic steatosis adjusted for BMI (rs738408:C>T, P = 1.92 × 10 −9 ; rs738409:C>G, P = 2.16 × 10 −9 ) (Cox et al., 2011; Wagenknecht et al., 2011; Palmer et al., 2013) , IMP4 with glucose effectiveness (rs72854959:G>T; P = 4.25 × 10 −9 ), and IDH1 with waist circumference (rs11554137:G>A; P = 2.45 × 10 −8 ) and BMI (rs11554137:G>A; P = 3.86 × 10 −8 ). The IDH1 associations have been observed previously in this dataset (Gao et al., 2015) .
Variants with Evidence of Both Linkage and Association
One variant, rs71508052:G>A, was found to have evidence of both linkage (LOD >3.0) and genome-wide significant association (P < 5.0 × 10 −8 ) with SBP (LOD = 3.74, P = 2.52 × 10 −9 ; Table 3 ). This variant maps to a locus on chromosome 10 purported to be a pseudogene predicted to have a regulatory function; however, this has not been functionally confirmed. Two additional genes contained variants showing both strong linkage and additional strong evidence of association with triglyceride levels: an intronic variant (rs189547099:G>C) in FNIP2 and a novel intronic variant (g.157997598C>G) in GLRB (P = 6.31 × 10 −8 , LOD = 3.13; both variants). Evaluation of suggestive variants (P = 5.0 × 10 −7 ; LOD >2.0) revealed six additional SNPs: rs2072560:C>T and rs651821:T>C in APOA5 with triglyceride levels (P = 5.14 × 10 −10 , LOD = 2.06; P = 3.67 × 10 −10 , LOD = 2.36, respectively), rs11554137:G>A in IDH1 with two adiposity-related traits (P = 2.45 × 10 −8 , LOD = 2.06, waist circumference; P = 3.83 × 10 −7 , LOD = 2.19, WHR_BMI), and three SNPs in MGRN1, SEC14L5, and ALG1 (rs748293549:C>T, rs763273802:G>A, and rs780440168:C>A, respectively) with percent body fat (P = 1.67 × 10 −7 , LOD = 3.26; all variants).
Adiponectin
The strongest evidence of both linkage and association in this sample was with the G45R variant in ADIPOQ with adiponectin levels (rs200573126:G>C; P = 4.53 × 10 −41 , LOD = 17.26). This finding is consistent with our previous results reporting a broad linkage peak on the distal q arm of chromosome 3 (Guo et al., 2006; Bowden et al., 2010; Hellwege et al., 2015) . As expected, including the presence of the functional variant G45R as a covariate in the analyses greatly diminished the linkage peak ( Figure S1 ) and decreased the magnitude of association for variants within the region. This adjusted analysis identified rs116505219:A>C in AQP12B, an aquaporin, which showed strong linkage with adiponectin levels after adjustment for G45R (LOD = 5.30; Table 1 ) as well as loci on chromosomes 10, 12, and 21 with LOD scores ࣙ4.5.
Comparison to Exome Chip
Of the 555,651 variants identified through sequencing of the exonic regions, 49,714 had previously been genotyped in Hispanics on the Illumina HumanExome Beadchip v1 (Hellwege et al., 2014) . WES identified 505,937 variants that were not on the exome chip; however, the chip included an additional 31,845 variants not seen in the WES sequencing, 14,218 of which were nonexonic. Although there were over 30,000 variants found in the exome chip dataset that were missing from the exome sequencing dataset, nearly half of these variants were nonexonic. In addition, the chip contains 4761 GWAS-enriched common variants, 3468 ancestry informative markers, and 3369 markers for identity-by-descent. A sizeable percentage of these subsets may not have been detectable by exome sequencing due to intergenic positioning.
Overall, there was a 5.2-fold increase in the number of informative variants detected by exome sequencing relative to the exome chip. Among the SNPs unique to the exome sequencing dataset, 151,175 (29.9%) were previously unidentified variants (dbSNP build 138). Comparison of the top 25 variants showing evidence of strong linkage or association with results from the exome chip, as well as variants showing evidence of both linkage and association, revealed very little overlap (i.e., WES largely revealed new results). The only variants among the top signals also found on the exome chip were rs200573126:G>C (ADIPOQ), rs2289043:T>C (UNC5C), rs738409:C>G (PNPLA3), and rs4917:T>C (AHSG).
Discussion
In this study, we performed a family-based linkage and association analysis of WES data from 78 Hispanic American families with cardiometabolic traits. We were able to evaluate the performance of WES data compared to an earlier analysis of exome chip data in this Hispanic sample. The primary goal of this work was to identify novel loci as well as known variants that were not included on the exome chip. Thus, we have evaluated 50 phenotypes related to anthropometry, glucose homeostasis, lipids, blood pressure, adiposity, hepatic fat and enzymes, and biomarkers. Considering the volume of results, some important observations can be noted. Most importantly, it is clear that many more exonic variants were identified using WES than the restricted catalog of SNPs included in chip-based genotyping. This greatly enhances the capability to identify strong candidate SNPs for cardiometabolic traits. Consequently, this analysis greatly expands the results from this discovery analysis for potential replication in other cohorts.
A major advantage of using an approach that integrates results from both linkage and association analyses is the opportunity to identify variants within a population that, although they may not reach genome-wide significance, still show a strong signal of both linkage and association. Here, two such variants are found within FNIP2 and GLRB with triglyceride levels. FNIP2 suppresses PPARGC1a RNA expression and is expressed in liver, pancreas, and adipose tissue (Hasumi et al., 2008) ; GLRB encodes the β unit of the glycine receptor, a neurotransmitter-gated chloride channel. The presence of insulin increases the effectiveness of glycine at its receptor (Caraiscos et al., 2007) . The variants within the two genes appear to be in LD (r 2 = 1). It is noteworthy that the variant in GLRB is a novel SNP identified in this population by WES.
One of the more notable linkage results was a broad peak spanning the majority of the p arm and a large region of the proximal q arm of chromosome 10, showing evidence of linkage with SBP. Located within this peak, on the q arm, is SLC18A3, encoding a 57 kDa vesicular acetylcholine transporter (VAchT) family protein, which assists in moving acetylcholine into secretory vesicles for extracellular release. The four variants showing strong linkage with SBP are located throughout the gene (two in the 3´-UTR, one in the 5´-UTR, and one synonymous coding variant). Previous reports have indicated that peripheral cholinergic systems are downregulated during systemic inflammation (Lips et al., 2007) , a co-morbidity of cardiometabolic disease, and that deterioration of cholinergic anti-inflammatory pathways promotes the development of hypertensive target organ damage, suggesting dysfunction of the VAchT (Li et al., 2011) . We further explored the linkage between variants within SLC18A3 and SBP by performing family-based linkage analysis. Of the two families showing nominal evidence of linkage, one appeared to show a distinct pattern of segregation of the minor allele with higher SBP values (mean SBP: major allele = 133.56, minor allele = 182.83). The number of carriers in the first family was low (n = 6), and the pattern was not repeated in the second family. However, the strongest evidence of linkage in our prior publication on exome chip data from this cohort, (rs7412 in APOE with plasma apolipoprotein B) also did not show strong family-specific linkage (Hellwege et al., 2014) . It is also noteworthy that within this broad linkage peak, there is an intronic variant (rs71508052:G>A) showing evidence of both linkage and genome-wide significant association with SBP. Interestingly, the variant is located within a predicted pseudogene of unknown function, NUTM2HP.
While we did observe linkage peaks on chromosomes 1 (acute insulin response) and 12 (G45R-adjusted adiponectin levels) consistent with our previous report (Hellwege et al., 2016) , the signals in the current report were not found to be as strong. This is likely due to the difference in sample sizes between the two studies; the exome chip analysis included up to 1414 participants from 90 families compared with 1205 samples from 78 families in the exome sequencing analysis. Nonetheless, the long arm of chromosome 1 is of particular interest, as linkage of this region with type 2 diabetes and metabolic syndrome has been documented in multiple populations, including Hispanics (Langefeld et al., 2004; Prokopenko et al., 2009) . Table S4 lists the variants included within the chromosome 1q linkage peak. Although none of the variants listed in the table were found in previous reports of linkage with acute insulin response, a different variant within F5 was reported to show genome-wide association with fasting serum levels of ferritin, one of a number of biomarkers included in a model to predict the 5-year risk of type 2 diabetes (Ahluwalia et al., 2015) .
The single variant showing the strongest evidence of linkage with SAT, rs2289043:T>C, is located within UNC5C. This gene encodes a member of the UNC5H family of receptors that has high protein expression levels in the luminal membranes of the gall bladder, intestine, and kidney (Uhlén et al., 2015) . UNC5C receptors bind netrin-1, a protein involved in both cell migration during neural development and macrophage retention in adipose tissue. Netrins have cell type-specific attractant and repellant properties; the repellant response is mediated by UNC5H and adenosine A2 B receptors Leonardo et al., 1997; Corset et al., 2000) . Recently, a suggestive association between an intronic variant (rs11097470:T>C) in UNC5C and energy balance (P = 5.14 × 10 −06 ) was reported in Hispanic children (Comuzzie et al., 2012) . High expression levels of netrin-1 have also been found in obese, but not lean, adipose tissue in both humans and mice (Ramkhelawon et al., 2014) . Taken together, this information suggests that alterations in UNC5C expression or structure could affect subcutaneous adipose tissue volume.
Several variants of biological relevance reached genomewide significant association. As mentioned above, specific variants in APOA5 are well known to have substantial effects on plasma triglyceride levels, particularly in African American and Hispanic populations (Pennacchio et al., 2002) . Consistent with our previous reports and those of others, variants within PNPLA3, a triacylglycerol lipase, were found to have a significant association with measures of hepatic density (Romeo et al., 2008; Cox et al., 2011; Wagenknecht et al., 2011; Palmer et al., 2013) . PNPLA3 is thought to be membrane-bound and may mediate energy storage and usage in adipocytes. IDH1 (isocitrate dehydrogenase 1) is a gene associated with waist circumference in a previous report analyzing GWAS and exome chip data (Gao et al., 2015) , although the variant identified was different than that reported in this study. Mutations in IDH1 have primarily been examined for their role in the pathogenesis of cancers, particularly glioma and acute myeloid leukemia (Fujii et al., 2016) . However, results from rodent models suggest that there may be a direct correlation between IDPc (cytosolic NAPD + -dependent isocitrate dehydrogenase) and adipose tissue levels and that IDPc may be a necessary cofactor during adipogenesis (Koh et al., 2004) .
Compared with our previous work using the HumanExome Bead Chip (Hellwege et al., 2014) , exome sequencing identified more than five times the number of polymorphic SNPs in this population. More importantly, the use of WES allowed for the discovery of novel variants, which accounted for nearly 30% of identified variants. While the exome chip did provide some insight into variants linked or associated with cardiometabolic disease, exome sequencing largely broadens that knowledge by vastly increasing the number of potential variants.
This study targeted genetic factors related to metabolic and cardiovascular disease in a Hispanic population. The majority of cardiometabolic genomic studies have been carried out in European-derived populations (Bowden, 2011) . Hispanics are underrepresented in the type 2 diabetes literature, despite an increased prevalence of type 2 diabetes in the United States for Hispanics compared with non-Hispanic whites (12.8% vs. 7.6% as of 2014) (CDC/NCHS, 2016) . In 2013, the most current data available, cardiovascular disease was the second leading cause of death among Hispanics, with diabetes ranked as the fifth leading cause (Below & Parra, 2016; Heron, 2016) . This report adds to the available literature on cardiometabolic disease in Hispanic populations.
This study, however, was not without limitations. Due to the cost of WES and the size of the study population, the sample used was relatively smaller in size, which can decrease statistical power. The analysis was limited to exons, miRNA, and untranslated regions; however, it is becoming clearer that many causal variants are intergenic or may be located in various noncoding RNAs other than miRNAs. It would be beneficial for future experiments to take advantage of familybased linkage and single-variant association analyses of WES data to identify the specific variants that significantly contribute to cardiovascular and metabolic diseases within this population.
In conclusion, WES data provided insights that were not able to be observed from exome chip data analysis and thus enabled identification of novel signals contributing to cardiometabolic traits. Further, the integration of results from two-point linkage and single-variant association analysis allowed for recognition of variants that may otherwise have been missed with either individual analysis separately. This study provided evidence that WES data, in combination with family-based linkage and association analyses, is a valuable tool in the discovery and identification of novel variants in complex disease.
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